ROIVANT SCIENCES LTD's ticker is and the CUSIP is G76279101. A total of 226 filers reported holding ROIVANT SCIENCES LTD in Q4 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,635,039 | – | 1,081,767 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VI Management, LLC | 1,119,489 | $12,571,861 | 98.63% |
| Patient Square Capital LP | 12,639,920 | $141,946,302 | 77.60% |
| QVT Financial LP | 112,541,536 | $1,263,841,449 | 71.60% |
| Two Seas Capital LP | 8,508,223 | $95,547,344 | 23.33% |
| Whitefort Capital Management, LP | 1,591,000 | $17,866,930 | 11.39% |
| Tyro Capital Management LLC | 1,345,981 | $15,115,367 | 10.65% |
| Tejara Capital Ltd | 2,134,895 | $23,974,871 | 10.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 73,031,667 | $820,145,620 | 7.30% |
| STEMPOINT CAPITAL LP | 2,169,116 | $24,359,173 | 6.50% |
| Anchorage Capital Group, L.L.C. | 4,832,642 | $54,270,570 | 6.46% |